We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Ronen Veksler, Co-Founder and CEO at Promise Bio. Promise Bio is an early-stage tech-bio company coming out of AION Labs in Israel with strategic investors – AstraZeneca and Pfizer. They’ve built a cloud-based AI platform that uses advanced mass spectrometry-based proteomics and provides value for pharmaceutical companies in 4 ways: identifies new drug targets, predicts treatment response, analyzes the mechanism of action, and supports pathway engagement analysis.
Check out the main topics of discussion for this episode of the Life Sciences Today podcast:
- Tell me about your journey to Promise Bio?
- Who are your customers?
- How do you create value for your customers?
- How do you capture value from them?
- What are 3 things you want to achieve for your customers in the next 12-18 months?
Now, without further ado, we’re excited to share with you the next episode of the Life Sciences Today podcast.
Be sure to subscribe to the Life Sciences Today on your favorite podcasting platform:
Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.
If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.
Thanks so much for listening!
